Submitted by Bob Burton on
Medicines Australia (MA), the peak drug industry lobby group, has unveiled details of how much its 42 member companies (and one non-member) spent in the last half of 2007 on each one of over 14,000 events that were designed to promote their drugs to doctors.
Submitted by Bob Burton on
A proposal before the Massachusetts state Senate to ban drug company gifts to doctors is generating controversy. "To imply that doctors who have invested years and tens of thousands of dollars in their profession can be bought with a dinner or a package of Post-its is beneath contempt," wrote the husband of one doctor. But Dr. Daniel J.
Submitted by Diane Farsetta on
Subliminal advertising may be "more effective than regular advertising, because people don't have time to raise their anti-ad defenses," according to a new study.
Submitted by Diane Farsetta on
Robin RaskinIn his new book True Enough: Learning to Live in a Post-Fact Society, Farhad Manjoo covers video news releases (VNRs) by looking a
Submitted by John Stauber on
In the brave new world of seemingly everyone having a MySpace page, publicity over alleged prostitution gave rise to a new online star at MySpace.
Submitted by Diane Farsetta on
Under the banner "a marketplace of ideas," major industry groups are blogging together, to "build influence and drive policy." The BizCentral blog includes the American Petroleum Institute, Business Roundtable,
Submitted by Diane Farsetta on
"I can't recall a time when PR has been as strong," Sir Martin Sorrell, the head of the UK-based marketing and public relations conglomerate WPP, told the Guardian.
Submitted by Anne Landman on
Submitted by Judith Siers-Poisson on
David Roberts of Grist.org writes in the Nation, "So there you have it: just in the past week, elite opinion against coal has accelerated, two major coal projects have run into embarrassments, and an independent report has confirmed that things are only going to get worse." Power consulting firm Wood MacKensie says that "the rate of coal plant cancellations accelerated during 2007 to the point that more than 50% of the new coal capacity announced since 2000 has now been canceled." On to
In early January, the U.S. House Committee on Energy and Commerce began investigating celebrity endorsements in television ads for brand-name drugs. The investigation was sparked by Pfizer's commercials for its best-selling cholesterol drug Lipitor. These direct-to-consumer (DTC) ads feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2024
Drug maker